Connection

Rebecca Bechhold to Immunoconjugates

Back to Details
This is a "connection" page, showing publications Rebecca Bechhold has written about Immunoconjugates.
Rebecca Bechhold
Connection Strength
0.123
Immunoconjugates
  1. EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer. J Clin Oncol. 2015 May 10; 33(14):1609-19.
    View in: PubMed
    Score: 0.123
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.